Simon Wegerif

Chief Scientist at Lifelight

Simon Wegerif is an accomplished professional with extensive experience in technology and business leadership. Currently serving as Chief Scientist and Signal Processing Consultant at Lifelight® since September 2018, Wegerif has contributed to pioneering smartphone-based clinical observation technology. As the Founder and Managing Director of HRV Fit Ltd since October 2009, Wegerif has been instrumental in developing innovative biomedical applications for measuring autonomic nervous system function. Prior roles include Vice President at NXP Semiconductors, where Wegerif led the creation of secure transaction standards for NFC, and Vice President and General Manager at Philips Semiconductors, focusing on the turnaround of the DVD recording business and commercialization of HDTV technology. Wegerif began a career at the BBC as a Project Design Engineer, earning two patents for digital audio transmission innovations. Educational qualifications include executive programs at Stanford University, a BSc in Electronic Engineering from the University of Sussex, and a postgraduate diploma in Management and Marketing from Nottingham Business School.

Location

Southampton, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Lifelight

Lifelight is game-changing technology that allows a mobile device to estimate blood pressure, pulse and breathing rate simply by looking into the device's built-in camera for up to 40 seconds. Completely contactless, with no additional hardware needed, it saves healthcare staff time while improving the patient experience. Today Lifelight is addressing health inequalities by detecting patients at risk of CVD early via an everyday mobile device, providing indicative vital signs to allow access to the right care pathway. Already a Class I medical device, with further market approvals on track, Lifelight is set to scale personal healthcare monitoring, through clinically actionable vital signs measurements. The potential is to enable patient-taken observations, leading to safer, easier, and more effective remote triage and monitoring.